Theriva Biologics WKN: A40MGC ISIN: US87164U5083 Forum: Aktien User: Summer.76

https://therivabio.com/press_releases/theriva-biologics-reports-third-quarter-2024-operational-highlights-and-financial-results/

🙋🌻

https://www.stocktitan.net/news/TOVX/theriva-biologics-selected-as-finalist-in-international-competition-zcgjb7d4srtb.html

Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant

https://therivabio.com/press_releases/theriva-biologics-announces-orphan-medicinal-product-designation-granted-by-the-european-commission-to-vcn-01-for-the-treatment-of-retinoblastoma/

https://therivabio.com/press_releases/theriva-biologics-announces-positive-outcome-of-data-and-safety-monitoring-committee-dsmc-review-in-phase-1b-2a-clinical-trial-of-syn-004-ribaxamase-in-allogeneic-hematopoietic-cell-trans/

🫢🌻

https://therivabio.com/press_releases/theriva-biologics-awarded-manufacturing-funding-from-the-spanish-governments-national-knowledge-transfer-program/

https://www.streetinsider.com/dr/news.php?id=23709548&gfv=1 Theriva Biologics (TOVX) Files for 2.17M Share and Warrant Offering

Auch mal hübsch für so einen Freitag Abend 😊

https://www.benzinga.com/news/24/08/40620101/why-affirm-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket ... • Theriva Biologics, Inc. (NYSE:TOVX) gained 24.3% to $4.35 in pre-market trading after the company announced it received a US patent application notice of allowance for treating C. Difficile disease and other antibiotic-induced GI tract adverse effects. ...

🧐

🍀